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A variety of dietary supplements have been proposed 
for the management of hypertension and other 
cardiovascular diseases, but the evidence for their efficacy 
is meagre.1 However, over the last few years, there is 
growing interest in the potential benefit of tea in 
cardiovascular protection. 2-4 Tea is the extract of Camellia 
sinensis, and one of the most widely enjoyed drinks.2,3 The 
leaves of the plant are rich in flavonoids, containing 
several phytochemicals including phenols and catechins, 
to which potent antioxidant, free radical scavenging, 
appetite-modifying and hypolipidemic effects have been 
ascribed.2-7 Long-term consumption of beverages 
containing catechins inhibits the formation of oxidized 
lipids and decreases body fat.5-9 Over 70% of flavonoids in 
green tea are catechins. Epigallocatechin-3-gallate 
(EGCG) is the cardinal (65%) catechin in green tea. In-
vitro studies have shown that the epigallocatechins in 
green tea have angiotensin converting enzyme inhibitor 
properties,10 and vasodilatory actions. 11 Molecular and 
animal studies have demonstrated that green tea catechins 
enhance processes, thought to stimulate bile acid 
production, decrease cholesterol concentration in the 
hepatocytes, inhibit intestinal absorption of lipids and 
upregulate low-density lipoprotein (LDL) receptors in the 
liver, mechanisms all leading to favorable blood lipid 
profile. 2-4,12,13  
Black tea also contains small amounts of catechins. 
However, due to the fermentation process of black tea, its 
primary antioxidant polyphenols are theaflavins and 
thearubigins, equally effective antioxidants to catechins. 14  
Tea is the most widely consumed beverage by people 
across the globe, next to water. Tea is manufactured in 
three basic forms, green, black and oolong tea.6 All forms 
of tea come from the leaves of the plant Camellia sinensis, 
however the processing that the leaves undergo to make 
the final tea is different. The leaves for black tea are fully 
oxidized, while those for green teas are lightly steamed 
before being dried, so that the oxidative enzymes are 
inactivated and the flavonoid contents are retained. Oolong 
tea is a partially oxidized product. Black tea represents 
approximately 72% of the total consumed tea in the world, 
whereas green tea accounts for 20-25% and oolong tea for 
<2%. Green tea is rich in the flavanol group of 
polyphenols, known as catechins, which may constitute up 
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to 30% of the dry leaf weight (Table 1). Other components 
include other polyphenols, caffeine (~3%), along with very 
small amounts of the other common methylxanthines, 
theobromine and theophylline. Thearubigins constitute the 
largest mass of the extractable matter in black tea. Oolong 
tea is intermediate in composition between green and black 
teas. Black teas mostly come from plantations in Africa, 
India, Sri Lanka and Indonesia, while green teas come 
from the Far East (China and Japan). As indicated above, 
black and green teas both contain similar amount of 
flavonoids, however they differ in their chemical structure. 
Green teas contain more of the simple flavonoids called 
catechins, while the oxidisation that the leaves undergo to 
make black tea converts these simple flavonoids to the 
more complex varieties called theaflavins and 
thearubigins. Although the oxidisation process modifies 
the type of flavonoids present, the total level and their 
overall antioxidant activity, is similar in both teas. 14  
Table 1. Components of Tea 
 
 Black Tea Green Tea 
Catechins 3-10% 30-42% 
Flavonols 6-8% 5-10% 
Theaflavins 3-6%  
Thearubigins 12-18%  
Methylxanthines 8-11% 7-9% 
Carbohydrates 15% 10-15% 
 
Cardiovascular disease (CVD) is the leading cause of 
morbidity and mortality in the industrialized world.15 
According to World Health Organization report, CVDs 
were accounted for 29% of all global deaths in 2004 and 
about 23.6 million people will die from CVDs by 2030. 2 
In the USA, CVD accounted for 32% of all deaths in 2010 
and more than one third of the U.S. population live with 
>1 types of CVD. 15 By 2030, 44% of the US population is 
projected to have some form of CVD. In most instances, 
CVD is attributed to atherosclerosis, a vascular chronic 
athero-thrombo-inflammatory condition. 16  
The cardiovascular effects of green tea consumption 
have been extensively studied in human as well as in 
animal models.2 There is accumulating evidence from 
epidemiological and human interventional studies that 
consumption of green tea is associated with decreased 
CVD risks. 17-22  
To date, many of the catechins’ effects have been 
demonstrated, although the exact underlying mechanisms 
have not been fully elucidated. The most important 
biological actions are their antioxidant and free radical 
scavenging properties.23 In addition to their direct 
antioxidant effect, they can also indirectly increase 
endogenous antioxidants to mitigate oxidative damage. 
Catechins can also protect cells from lipid peroxidation 
and DNA deamination induced by oxidative stress. 
Epigallocatechin gallate (EGCG) has been shown to 
modulate apoptotic pathways to protect against oxidative 
stress. Catechins can also modulate apoptosis by altering 
antiapoptotic and proapoptotic gene expression. However, 
a divergent effect of catechins on apoptotic pathways may 
exist, as in low concentrations catechins may demonstrate 
antiapoptotic effects, while high doses may promote 
apoptosis. Similarly, in addition to the evidence of 
catechin-conferred cytoprotection via antioxidant and 
antiapoptotic actions, other observations suggest that 
catechins may also be prooxidant, mostly at high 
concentrations. However, the prooxidant effects of high-
dose catechins may induce an up-regulation of endogenous 
antioxidants, which may enhance cytoprotection. 
Additionally, catechins appear to have anti-inflammatory 
effects,18 partly due to their scavenging of nitric oxide 
(NO) and reduction of NO synthase (NOS) activity, and/or 
the inhibition of inducible NOS (iNOS).  
The antilipidemic properties of catechins have been 
well-documented and can lead to CVD prevention. They 
have been shown to inhibit the oxidative modification of 
LDL. 13 Furthermore, catechins can inhibit LDL-induced 
human vascular smooth muscle proliferation, which is 
associated with atherogenesis. 2,24,25  
In vitro and in vivo studies have suggested potential 
antiplatelet and antithrombotic effects of tea catechins.2 
Exposure of human platelet concentrates to EGCG has 
been shown to maintain platelet aggregability and preserve 
platelets by inhibiting platelet activation and apoptosis. 
There is accumulating evidence that tea catechin 
supplementation may improve platelet aggregation and 
thrombosis through diverse mechanisms. 
Finally, catechins have proven efficacy as prophylactic 
and neuroprotective agents against neurodegenerative/ 
neuroinflammatory diseases such as Parkinson’s disease, 
Alzheimer’s disease and multiple sclerosis, primarily due 
to their antioxidant and anti-inflammatory properties.23 
Catechins are also potent agents in preventing the neuronal 
damage that occurs after a stroke. 23  
Many cell culture and animal studies have shown that 
catechins are potent natural inhibitors of several tyrosine 
kinase receptors (RTKs). 24 Enhanced RTK activity has 
been associated with the development of proliferative 
diseases such as atherosclerosis and cancer. Hence, 
catechins, which inhibit the growth factor-RTK-mediated 
signal transduction pathways and exert an antiproliferative 
/ antiapoptotic effect, can have a role in the prevention and 
management of such diseases.  
Case-control, epidemiological, and small randomized 
controlled studies and several meta-analyses and reviews 
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have suggested that tea intake has a cardioprotective effect, 
with beneficial effect on blood pressure, insulin resistance, 
inflammation and oxidative stress, and on lipid profile in 
patients with cardiovascular disease.13,19-22,25-27  
In a Polish double-blind, placebo-controlled trial, 56 
obese, hypertensive patients were randomized to receive a 
daily supplement of 1 capsule that contained either 379 mg 
of green tea extract or a matching placebo, for 3 months.18 
According with these results, daily supplementation with 
379 mg of green tea extract favorably influenced blood 
pressure, insulin resistance, inflammation and oxidative 
stress, and lipid profile in this small cohort of patients with 
obesity-related hypertension. 18  
According to a Japanese study, men who drank >4 cups 
of green tea per day exhibited an inverse association with 
coronary atherosclerosis.19 The favorable effect of 
catechins on vascular diseases has been ascribed, in part, 
to the catechins’ antioxidant properties that prevent low-
density lipoprotein (LDL) oxidation. 20  
A meta-analysis of 20 randomized controlled trials 
comprising 1536 subjects revealed a significant, albeit 
small, reduction in systolic blood pressure conferred by 
green tea (mean difference-MD: -1.94 mmHg; p = 
0.0002).21 Similar results were also observed for total 
cholesterol (MD: -0.13 mmol/l; p < 0.0001) and LDL 
cholesterol (MD: -0.19 mmol/l; p = 0.0004). The authors 
concluded that green tea intake results in significant 
reductions in systolic blood pressure, total cholesterol, and 
LDL cholesterol.  
Another recent meta-analysis of 13 randomized 
controlled trials evaluating the effects of green tea on 
blood pressure in 1,367 subjects suggested that green tea 
consumption significantly decreased systolic (by -1.98 
mmHg; P <0.001), and diastolic blood pressure (by -1.92 
mmHg; P = 0.002), compared with the control group. 22 
Subgroup analyses suggested that the positive effect of 
green tea polyphenols on blood pressure was only showed 
in studies using a low-dose green tea polyphenol, and with 
long-term tea intake, and in those studies which excluded 
the confounding effects of caffeine. The authors concluded 
that low-dose long-term green tea consumption had a 
favorable effect on blood pressure.  
A recent meta-analysis of 11 studies examined the 
effect of black tea (4-5 cups/day) on blood pressure in 378 
patients. 26 The pooled mean effect of regular tea ingestion 
was -1.8 mmHg (P = 0.0013) for systolic and -1.3 mmHg 
(P<0.0001) for diastolic blood pressure. In covariate 
analyses, studies using tea extract powders found larger 
reductions in systolic blood pressure than studies using leaf 
tea. Baseline systolic and diastolic blood pressure had a 
significant impact on the effect of tea ingestion on blood 
pressure, with a ~1 mmHg larger reduction for every 10 
mmHg higher baseline blood pressures. The authors 
concluded that regular consumption of black tea can 
reduce blood pressure.  
In a review of 11 randomized controlled trials with a 
total of 821 individuals, 7 trials examining intake of green 
tea and 4 trials examining intake of black tea, the results 
suggested that tea has favourable effects on CVD risk 
factors.3 Black tea was found to produce significant 
reductions in LDL cholesterol (mean difference – MD, 
0.43 mmol/L) and blood pressure (systolic blood pressure 
–SBP: MD -1.85 mmHg; diastolic blood pressure - DBP: 
MD -1.27 mmHg) over 6 months. Green tea was also found 
to produce significant reductions in total cholesterol (MD 
-0.62 mmol/L), LDL cholesterol (MD -0.64 mmol/L) and 
blood pressure (SBP: MD -3.18 mmHg; DBP: MD -3.42). 
When both tea types were analyzed together, they showed 
favourable effects on LDL cholesterol (MD - 0.48 
mmol/L) and blood pressure (SBP: MD -2.25 mmHg; 
DBP: MD -2.81 mmHg).  
 In another recent meta-analysis of 21 randomized 
controlled trials examining the effects of tea intake on 
blood pressure in 1323 subjects, the mean systolic and 
diastolic blood pressures were -1.8 mmHg and -1.4 mmHg 
lower, respectively, in individuals drinking tea compared 
with the controls.27 Subgroup analyses showed that the 
blood pressure-lowering effect was apparent in the 
subjects who consumed tea over a median of 12 weeks and 
for both green and black types of tea. The authors 
concluded that long-term (>12 weeks) ingestion of a tea 
(green and black tea) resulted in a significant reduction in 
systolic and diastolic blood pressure. 
A final word of caution relates to usage of green tea 
extract capsules containing very high doses of polyphenols 
and EGCG (up to 750 mg of polyphenols per tablet) and 
involves liver toxicity.21, 28 Recommended daily allowance 
should be limited to 10 mg of extract per kg of body weight 
with maximum dose of 750 mg/day. It is difficult to exceed 
the recommended daily allowance by drinking green tea. 
A cup of green tea contains on average only 80 mg of 
EGCG. In countries, like China, Japan, India, where 
people regularly drink 9 - 10 glasses of green tea a day, no 
cases of toxicity have been reported. Toxicity involves 
only green tea extract capsules, and in most cases, liver 
function returns to normal upon discontinuation of high 
dosage of EGCG. According to randomized controlled 
studies, adverse events may occur where the daily intake 
of EGCG exceeded 200 mg. Animal and in vitro studies 
have shown that there could be an increased risk of adverse 
events when concentrated green tea is consumed on an 
empty stomach.21 On the other hand, in vivo studies have 
shown that green tea consumption may be 
hepatoprotective, and pharmacokinetic studies in humans 
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have demonstrated that green tea consumption is quite 
safe. 21  
Although promising human and animal data have been 
accumulated indicating a cardioprotective effect of tea 
flavonoids, either green tea catechins or black tea 
thearubigins and theaflavins, further rigorous and well-
designed randomized controlled human interventional 
trials are needed to confirm and provide better 
understanding of the potential beneficial effects of tea on 
cardiovascular disease. 
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